Physician profile
Gregory T Frey
NPI 1326225343
$7,967.51
in general payments reported to CMS, 2019-2025
7 companies · $7,248 in 2025
The $7,248 reported for 2025 was more than what 88% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2022: $73.26 · 2023: $453 · 2025: $7,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,288 · Travel and Lodging: $1,146 · Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,288.00 |
| Travel and Lodging | $1,146.15 |
| Food and Beverage | $267.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $7,146.15 | 2025 | |
| Medtronic, INC. | $288.00 | 2023 | Amplatz Goose Neck |
| Siemens Medical Solutions USA, INC. | $219.75 | 2019-2023 | Somatom Edge Plus, Artis Q Floor, Artis Q Ceiling |
| Photocure INC | $102.07 | 2025 | Cysview |
| W. L. Gore & Associates, INC. | $73.46 | 2019 | |
| Profound Medical Corp. | $73.26 | 2022 | |
| Philips North America LLC | $64.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.